https://t.co/G7gv7Gp9kv ...

Urogen Pharma (URGN) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to a loss of $0.8 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.18%. A quarter ago, it was expected that this company would post a loss of $0.72 per share when it actually produced a loss of $0.69, delivering a surprise of +4.17%.Over the last four quarters, the company has surpasse ...

[Table_Title] 大族数控(301200.SZ/03200.HK) AI PCB 浪潮已至，钻孔设备国产先行者 [Table_Summary] 核心观点： 盈利预测： | [Table_ 单位 Finance] :人民币百万元 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入 | 1,634 | 3,343 | 6,262 | 8,960 | 12,366 | | 增长率（ % ） | -41.3% | 104.6% | 87.3% | 43.1% | 38.0% | | EBITDA | 237 | 458 | 1,018 | 1,565 | 2,318 | | 归母净利润 | 136 | 301 | 820 | 1,309 | 1,981 | | ） 增长率（ % | -68.8% | 122.2% | 172.1% | 59.7% | 51.4% | | EPS（元/股） | 0.32 | 0.72 | 1.72 | 2.75 | 4.16 | | 市盈率（P/E） | ...

The US Supreme Court refused to consider requiring Major League Baseball to comply with federal antitrust law https://t.co/Ht76pW902w ...

Right now, China is a bystander as the bombs fall on Iran. It will not remain one when the rebuilding starts https://t.co/7DZyJbBGVY ...

Summary of Establishment Labs FY Conference Call Company Overview - **Company**: Establishment Labs (NasdaqCM: ESTA) - **Industry**: Medical Devices, specifically breast implants Key Points 2025 Performance and 2026 Outlook - Establishment Labs had an outstanding performance in 2025, exceeding initial expectations with the successful launch of the Motiva implant, opening 1,500 accounts, which was beyond the original plan [9][10] - The company expects strong momentum to continue into 2026, with guidance indicating at least 30% revenue growth, aiming for a midpoint revenue of $265 million [30][31] Drivers of Success - The success in 2025 was attributed to innovative marketing strategies, including partnerships with influencers and celebrities like Meghan Trainor, which significantly increased demand [13][15] - The company has been adding new accounts consistently, with a commercial team that reportedly hasn't gone a day without adding a new account [8][10] - The Preservé launch outside the U.S. has also been successful and is expected to drive growth in 2026 [11] Pricing Strategy - The pricing strategy for Motiva has been effective, with no significant pushback from the market. The company has maintained premium pricing due to the perceived value of their products [17][18] - Surgeons are reportedly charging a premium for procedures using Motiva, with increases of 30%-50% for those surgeries [46][50] Market Dynamics - The U.S. market has shown a stable demand for Ergonomix implants, with approximately 55%-60% of sales coming from this premium product line [21] - The company anticipates that the introduction of smaller size Motiva implants will capture an additional 10% of the market [65] International Business - Establishment Labs is focusing on direct markets, which offer better economics, and has seen healthy growth in international markets [71][72] - The company is optimistic about the Chinese market, expecting to achieve a dominant share similar to other Asian markets [73] Future Innovations and Expansion - The company is preparing for the reconstruction market, which could double their total addressable market (TAM). They are awaiting FDA approval for their reconstruction products [58][60] - Establishment Labs aims to democratize breast reconstruction and improve aesthetic outcomes, which could drive further adoption [63] Margin Expansion - The company expects gross margin expansion as they shift focus to higher-margin products and reduce dependency on distribution markets [67] Strategic Leadership Changes - The transition of CFO Raj Denhoy to a strategic role within the company is seen as a move to enhance business development and innovation initiatives [32][38] Additional Insights - The company has a conservative guidance approach, learning from market dynamics as they grow in the U.S. [31] - There is potential upside in revenue projections, particularly with the Preservé product line and the minimally invasive portfolio [74][76] This summary encapsulates the key insights from the Establishment Labs FY Conference Call, highlighting the company's strong performance, strategic initiatives, and future growth potential in the breast implant market.

Apple speeds up the iPad Air with an M4 upgrade, starting at $599 https://t.co/nwSMFDqDsJ ...

2026 年 03 月 02 日 债券研究周报 证券分析师： 颜子琦 S0350525090002 [Table_Title] 两会前，债市情绪转为谨慎 债券研究周报 最近一年走势 相关报告 《债券研究周报：新年复工，债市情绪继续回暖* 颜子琦》——2026-02-25 《固定收益深度研究：读懂 2026（一）：各省市 "十五五"规划建议中的产业蓝图*颜子琦》—— 2026-02-12 《债券研究周报：10 年国债破位 1.80%，债市情 绪边际回升*颜子琦》——2026-02-10 《债券研究周报：债市情绪继续谨慎*颜子琦》— —2026-02-02 《债券研究周报：长债修复后，债市情绪仍偏谨慎 *颜子琦》——2026-01-26 本篇报告解决了以下核心问题：最新一周债市卖方与买方的观点情绪变 化。 从我们统计的债市情绪指数来看，上周（02 月 24 日-03 月 02 日）债市 出现较大幅度调整，带动买卖方情绪指数回落，买方情绪相对回落更多。 地产、通胀的后续演变还需观察，关注预期差带来的机会，两会期间债 市仍有上涨可能，建议逢调整进行布局。 卖方视角，债市情绪有所下降。基于对 28 家卖方机构观点的统计 ...

石油石化行业：油价上涨明显，美 国原油进出口数量增多 受到美以伊军事冲突的大幅推动国际油价开盘即跳涨。当地时间 2026 年 2 月 28 日，伊朗局势进入了军事冲突爆发阶段。截至北京时间 3 月 2 日 10:00，多 家航运巨头宣布暂停通过该海峡，霍尔木兹海峡承载了全球 1/5 的油气运输， 此次冲突可能蔓延至整个中东地区。截至北京时间 2026 年 3 月 2 日，WTI 开 盘价 75.00 美元/桶，较上一工作日收盘价（67.02 美元/桶）上涨 7.98 美元/ 桶，涨幅 11.9%，最高涨至 75.33 美元/桶；布伦特开盘价 81.57 美元/桶，较 上一工作日收盘价（72.87 美元/桶）上涨 8.7 美元/桶，涨幅 11.94%，最高涨 至 82.37 美元/桶。 原油价格环比上升明显。截至 2026 年 2 月 27 日，Brent 原油期货结算价为 72.48 美元/桶，环比上月涨 1.77 美元/桶，涨幅为 2.50%；WTI 原油期货结算 价为 67.02 美元/桶，环比上月涨 1.60 美元/桶，涨幅为 2.45%。Brent 原油现 货价格为 70.84 美元/桶，环比上月涨 ...

US manufacturing expanded in February but input prices soared at the fastest pace since 2022, stoking fears of an inflation resurgence even before this weekend's attacks on Iran. https://t.co/tabfuItEJi ...